About A2A Pharmaceuticals
A2A Pharmaceuticals is a company based in New York (United States) founded in 2016 by Matthew Welsch and Edward Painter.. A2A Pharmaceuticals has raised $250 thousand across 1 funding round from investors including IndieBio. The company has 5 employees as of December 31, 2024. A2A Pharmaceuticals offers products and services including AI Computational System, MLL-Menin Program, and COVID-19 Inhibitors. A2A Pharmaceuticals operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Paratek Pharma and Antheia, among others.
- Headquarter New York, United States
- Employees 5 as on 31 Dec, 2024
- Founders Matthew Welsch, Edward Painter
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name A2a Pharmaceuticals Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$250 K (USD)
in 1 rounds
-
Latest Funding Round
$250 K (USD), Seed
Oct 07, 2016
- Investors
-
Employee Count
5
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of A2A Pharmaceuticals
A2A Pharmaceuticals offers a comprehensive portfolio of products and services, including AI Computational System, MLL-Menin Program, and COVID-19 Inhibitors. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Platform for accelerating novel drug discovery using AI
AI-based initiative for cancer drug alternatives
Development of Mpro inhibitors for infectious diseases
Unlock access to complete
Software Development Team
1 people
Operations Team
1 people
Co Team
1 people
Leadership Team
1 people
Unlock access to complete
Funding Insights of A2A Pharmaceuticals
A2A Pharmaceuticals has successfully raised a total of $250K through 1 strategic funding round. The most recent funding activity was a Seed round of $250 thousand completed in October 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Seed — $249,997
-
First Round
First Round
(07 Oct 2016)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2016 | Amount | Seed - A2A Pharmaceuticals | Valuation | IndieBio |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in A2A Pharmaceuticals
A2A Pharmaceuticals has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include IndieBio. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Biotech startups are accelerated through IndieBio's focused programs.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by A2A Pharmaceuticals
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - A2A Pharmaceuticals
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
A2a Pharmaceuticals Comparisons
Competitors of A2A Pharmaceuticals
A2A Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Paratek Pharma and Antheia, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Therapeutics for antimicrobial resistant infections are developed.
|
|
| domain | founded_year | HQ Location |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on A2a Pharmaceuticals
Frequently Asked Questions about A2A Pharmaceuticals
When was A2A Pharmaceuticals founded?
A2A Pharmaceuticals was founded in 2016.
Where is A2A Pharmaceuticals located?
A2A Pharmaceuticals is headquartered in New York, United States. It is registered at New York, New York, United States.
Is A2A Pharmaceuticals a funded company?
A2A Pharmaceuticals is a funded company, having raised a total of $250K across 1 funding round to date. The company's 1st funding round was a Seed of $250K, raised on Oct 07, 2016.
How many employees does A2A Pharmaceuticals have?
As of Dec 31, 2024, the latest employee count at A2A Pharmaceuticals is 5.
What does A2A Pharmaceuticals do?
A2A Pharmaceuticals was founded in 2016 in New York, United States, within the biopharma sector. Novel drugs are developed to address antibiotic-resistant infections, tuberculosis, and cancer needs. A proprietary SCULPT platform integrates target data to construct and evaluate small molecule libraries iteratively. The preclinical pipeline encompasses oncology candidates AO-001 and AO-102, alongside antibiotic programs targeting LpxC and AroK in gram-negative bacteria.
Who are the top competitors of A2A Pharmaceuticals?
A2A Pharmaceuticals's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
What products or services does A2A Pharmaceuticals offer?
A2A Pharmaceuticals offers AI Computational System, MLL-Menin Program, and COVID-19 Inhibitors.
Who are A2A Pharmaceuticals's investors?
A2A Pharmaceuticals has 1 investor. Key investors include IndieBio.